Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension

Basic and Clinical Pharmacology and Toxicology- United States

doi 10.1111/bcpt.12800

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

The Angiotensin II AT2Receptor Is an AT1Receptor Antagonist

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

Case Reports in Pediatrics
2018English

Olmesartan Medoxomil Combined With Hydrochlorothiazide for the Treatment of Hypertension

Vascular Health and Risk Management
PharmacologyCardiologyEndocrinologyPublic HealthHematologyEnvironmentalCardiovascular MedicineMedicineOccupational HealthMetabolismDiabetes
2006English

Hronotherapy Aspects of Efficiency Azilsartan Medoxomil in Combination Therapy in Patients With Hypertension and Metabolic Syndrome

Kardiologiya
Cardiovascular MedicineCardiology
2016English

Angiotensin II Type 2 Receptor Gene Transfer Elicits Cardioprotective Effects in an Angiotensin II Infusion Rat Model of Hypertension

Physiological Genomics
GeneticsPhysiology
2004English

Olmesartan Medoxomil, an Angiotensin II Receptor Blocker Ameliorates Insulin Resistance and Decreases Triglyceride Production in Fructose-Fed Rats

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2004English

Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension

Hypertension
Internal Medicine
1999English

Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2002English

Effects of YM358, an Angiotensin II Type 1(AT1) Receptor Antagonist, and Enalapril on Blood Pressure and Vasoconstriction in Two Renal Hypertension Models.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy